Mergers & Acquisitions in USA: Frequently Asked Questions

M&A transactions in the USA are governed by a combination of federal statutes, state corporate law, and sector-specific regulation that together create one of the most demanding deal environments in the world. For international buyers and sellers, the process raises practical questions at every stage - from choosing the right deal structure to navigating antitrust clearance and managing post-closing liability. This article addresses the most frequently asked legal and commercial questions about US mergers and acquisitions, covering deal structures, regulatory filings, due diligence, representations and warranties, and dispute resolution, so that business owners and executives can approach a US transaction with a clear understanding of what to expect.

US M&A law does not operate under a single unified code. Instead, it draws from the Delaware General Corporation Law (DGCL), the Model Business Corporation Act adopted in many other states, federal securities legislation including the Securities Exchange Act of 1934 and the Securities Act of 1933, antitrust statutes such as the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), and a dense body of case law developed primarily in the Delaware Court of Chancery.

The choice of state of incorporation matters enormously. Delaware is the dominant jurisdiction for large US corporations because its courts have developed predictable, sophisticated corporate law over decades. A buyer acquiring a Delaware-incorporated target will encounter fiduciary duty standards, appraisal rights under DGCL Section 262, and merger mechanics under DGCL Section 251 that differ materially from those in other states. Many international clients assume that US law is uniform across states, which is a costly misconception.

Federal law overlays state corporate law in several critical areas. The Securities Exchange Act governs tender offers and proxy solicitations for public companies. The HSR Act requires pre-merger notification to the Federal Trade Commission (FTC) and the Department of Justice (DOJ) when transaction size thresholds are met. The Committee on Foreign Investment in the United States (CFIUS) reviews acquisitions by foreign persons that could affect national security. Each of these federal regimes operates on its own timeline and can independently delay or block a transaction.

A non-obvious risk for international buyers is the interaction between state and federal timelines. A deal can clear HSR review but still face a CFIUS investigation that extends the closing by several months. Planning for parallel regulatory tracks from the outset is essential.

The three primary deal structures in US M&A are the asset purchase, the stock purchase, and the statutory merger. Each carries distinct tax consequences, liability profiles, and transactional complexity.

In an asset purchase, the buyer acquires specified assets and assumes only the liabilities it expressly agrees to take on. This structure is attractive when the target carries contingent liabilities - pending litigation, environmental obligations, or underfunded pension plans - that the buyer wants to leave behind. The seller retains the corporate shell and its historical liabilities. A common mistake is assuming that an asset purchase eliminates all successor liability: under federal and state doctrines, courts can impose liability on asset buyers in areas such as product liability, environmental contamination, and certain employment claims even when the purchase agreement excludes those liabilities.

In a stock purchase, the buyer acquires the equity of the target entity and steps into the shoes of the selling shareholders. All historical liabilities travel with the company. This structure is simpler from a transfer perspective - contracts, licenses, and permits remain with the target without requiring third-party consents in most cases - but the buyer assumes full exposure to unknown liabilities. Representations and warranties insurance (RWI) has become a standard tool to manage this risk in mid-market and large transactions.

A statutory merger under DGCL Section 251 or its equivalent in other states involves one entity absorbing another by operation of law. The surviving entity acquires all assets and liabilities of the merged entity automatically. Forward triangular mergers - where the buyer creates a subsidiary that merges with the target, leaving the target as the surviving subsidiary - are widely used to insulate the buyer';s parent from target liabilities while preserving the target';s contracts and licenses.

The tax dimension often drives structure selection. Asset purchases generally allow the buyer to step up the tax basis of acquired assets, generating future depreciation deductions. Stock purchases do not automatically provide a step-up unless a Section 338(h)(10) or Section 336(e) election is made under the Internal Revenue Code. Sellers typically prefer stock sales because gains are taxed at capital gains rates rather than ordinary income rates applicable to asset sales at the corporate level.

To receive a checklist on deal structure selection for M&A transactions in the USA, send a request to info@vlolawfirm.com.

The HSR Act requires parties to notify the FTC and DOJ before closing transactions that exceed specified size thresholds. The thresholds are adjusted annually. As a general matter, a filing is required when the transaction value exceeds the applicable size-of-transaction threshold and, in some cases, when the parties meet size-of-person thresholds based on annual net sales and total assets.

Once a filing is made, the parties must observe a waiting period - typically 30 calendar days for standard transactions - before closing. The agencies may issue a Second Request, which is a formal demand for additional documents and information. A Second Request effectively extends the waiting period until the parties substantially comply, a process that can take several months and cost millions of dollars in legal and document review fees. Transactions in concentrated markets or involving direct competitors are most likely to attract a Second Request.

The practical burden of HSR compliance is frequently underestimated by international buyers making their first US acquisition. Document collection for a Second Request can involve hundreds of thousands of emails and internal documents. Privilege review, translation of foreign-language materials, and coordination across multiple jurisdictions add further complexity. Buyers should budget for this possibility from the outset and negotiate appropriate outside-date provisions in the purchase agreement to accommodate extended review.

Early engagement with antitrust counsel before signing is advisable. Counsel can assess the likelihood of a Second Request, identify potential remedies such as divestitures that might resolve competitive concerns, and advise on whether to approach the agencies informally before filing. A common mistake is treating HSR as a routine administrative step rather than a substantive regulatory process.

Beyond HSR, sector-specific approvals may be required. Acquisitions in banking, insurance, telecommunications, defense, and healthcare are subject to additional federal and state regulatory review. Each sector has its own timeline and substantive standards, and failure to identify all required approvals before signing can create serious closing risk.

Due diligence in a US transaction is broader in scope than in most other jurisdictions. It covers legal, financial, tax, environmental, intellectual property, employment, and regulatory matters, and in larger transactions it is conducted simultaneously across all workstreams under tight timelines.

Legal due diligence focuses on the target';s corporate records, material contracts, litigation exposure, intellectual property ownership, real property, and regulatory compliance. A key area of focus is change-of-control provisions in material contracts: many commercial agreements, financing arrangements, and government contracts contain provisions that require counterparty consent or trigger termination rights upon a change of control. Failure to identify and address these provisions before closing can result in the loss of critical business relationships immediately after the transaction closes.

Employment and benefits due diligence deserves particular attention. The Employee Retirement Income Security Act of 1974 (ERISA) imposes significant liability for underfunded defined benefit pension plans, and this liability can transfer to a buyer in a stock purchase or merger. Multi-employer pension plan withdrawal liability under ERISA Section 4201 is a specific risk in industries with unionized workforces. Many international buyers are unfamiliar with the scale of US pension liability and discover it only after closing.

Environmental due diligence is governed by the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), which imposes strict, joint, and several liability on current and former owners of contaminated property. A buyer that acquires a target owning contaminated real estate can face cleanup costs that dwarf the purchase price. Phase I and Phase II environmental assessments are standard practice, and the innocent landowner defense under CERCLA Section 107(b)(3) requires completion of all appropriate inquiries before closing.

Intellectual property due diligence must verify that the target actually owns the IP it claims to own. In the US, IP ownership in employment contexts is governed by work-for-hire doctrine under the Copyright Act of 1976 and by assignment agreements. A common finding is that early-stage companies failed to obtain written IP assignments from founders or contractors, leaving ownership of core technology legally uncertain.

In practice, it is important to consider that data room quality in US transactions varies widely. Sellers in private equity-backed transactions typically provide well-organized, comprehensive data rooms. Founder-led businesses often have incomplete records, missing corporate minutes, and undocumented arrangements. Buyers should calibrate their diligence intensity to the seller';s sophistication and the transaction';s risk profile.

To receive a checklist on due diligence priorities for US M&A transactions, send a request to info@vlolawfirm.com.

The representations and warranties section of a US purchase agreement is typically the most heavily negotiated part of the document. Representations are factual statements about the target made as of signing and closing. Warranties are promises that those statements are true. Breach of a representation or warranty gives the buyer a claim for indemnification.

US purchase agreements are notably more detailed than their equivalents in most civil law jurisdictions. A standard agreement for a mid-market transaction will contain representations covering corporate organization, capitalization, financial statements, absence of undisclosed liabilities, material contracts, intellectual property, real property, environmental matters, employment and benefits, tax, compliance with laws, and absence of material adverse change. Each representation is qualified by materiality thresholds, knowledge qualifiers, and disclosure schedules that carve out known exceptions.

The indemnification framework defines the economic consequences of a breach. Key negotiated terms include the survival period - the time after closing during which claims can be brought, typically 12 to 24 months for general representations and longer for fundamental representations such as capitalization and authority - the deductible or basket below which claims are not compensable, the cap on total indemnification liability, and the exclusive remedy provision that limits the buyer to contractual indemnification rather than tort or statutory claims.

Representations and warranties insurance has transformed risk allocation in US M&A over the past decade. RWI policies allow buyers to make claims directly against an insurer rather than the seller, enabling sellers to achieve a clean exit and distribute sale proceeds to their investors without maintaining an escrow. Policy limits typically range from 10% to 20% of enterprise value, and premiums generally fall in a range of 2% to 4% of the policy limit. RWI does not cover known risks disclosed in the data room or purchase agreement, fraud by the insured, or certain categories such as pension underfunding and environmental contamination in many policies.

A non-obvious risk is the interaction between the exclusive remedy clause and fraud carve-outs. Most US purchase agreements preserve fraud claims outside the indemnification cap, but the definition of fraud varies. Some agreements require intentional misrepresentation with knowledge of falsity; others include reckless disregard. The scope of the fraud carve-out can determine whether a buyer has meaningful recourse if the seller concealed material information.

CFIUS is an interagency committee chaired by the Secretary of the Treasury that reviews acquisitions by foreign persons that could threaten US national security. Its authority derives from the Defense Production Act of 1950 as amended by the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA).

CFIUS jurisdiction extends to "covered transactions," which include acquisitions of control over US businesses and, under FIRRMA, certain non-controlling investments in US businesses that operate in critical technology, critical infrastructure, or sensitive personal data sectors. The definition of control is broad and includes the ability to determine or direct important matters affecting the business, not just majority ownership.

Mandatory filing is required for certain transactions involving US businesses that produce, design, test, manufacture, or develop critical technologies subject to US export controls, and for acquisitions of substantial interests in TID US businesses (technology, infrastructure, and data) by foreign governments or entities in which a foreign government has a substantial interest. Voluntary filing is available for other covered transactions and is strongly advisable even when not mandatory, because CFIUS retains jurisdiction to review transactions that were not filed, potentially years after closing.

The CFIUS review process has two phases. The initial review period is 30 days, after which CFIUS may clear the transaction, open a full investigation of up to 45 additional days, or negotiate mitigation measures. Mitigation agreements - known as national security agreements or letters of assurance - impose ongoing obligations on the parties, such as restrictions on foreign national access to technology, board composition requirements, or data localization obligations.

The risk of inaction is significant. A foreign buyer that closes a covered transaction without filing and later faces a CFIUS investigation can be required to divest the acquired business. Divestiture orders have been issued in high-profile transactions involving Chinese acquirers, but CFIUS scrutiny extends to buyers from a wide range of countries depending on the nature of the US business.

In practice, it is important to consider that CFIUS timelines are not guaranteed. The committee can extend review periods, request additional information, and in complex cases take significantly longer than the statutory periods suggest. Buyers should negotiate purchase agreement outside dates that accommodate CFIUS review and include appropriate termination rights and reverse termination fees if CFIUS clearance is not obtained.

The closing of a US M&A transaction involves the simultaneous exchange of the purchase price for the equity or assets being acquired, together with the delivery of closing documents including officer certificates, legal opinions in some transactions, payoff letters for debt being repaid at closing, and consents from third parties identified in due diligence.

Purchase price adjustments are standard in US transactions. The most common mechanism is a working capital adjustment, which compares the target';s actual working capital at closing to a negotiated target amount. If actual working capital is below the target, the purchase price is reduced; if above, it is increased. The adjustment is typically calculated on a post-closing basis using a preliminary estimate at closing followed by a final determination within 60 to 90 days. Disputes over working capital adjustments are common and are typically resolved by an independent accounting firm acting as an expert, not an arbitrator, under the purchase agreement';s dispute resolution mechanism.

Earnouts are contingent consideration mechanisms that tie a portion of the purchase price to the target';s post-closing performance. They are frequently used when buyer and seller disagree on valuation, particularly in transactions involving early-stage companies, businesses with significant growth potential, or targets in volatile industries. Earnout disputes are among the most litigated issues in US M&A. Common sources of conflict include the buyer';s post-closing operational decisions that affect earnout metrics, accounting methodology disputes, and the interaction between earnout covenants and the buyer';s integration plans.

Delaware courts have consistently held that buyers owe a duty to operate the acquired business in good faith during the earnout period when the purchase agreement contains an express covenant to do so. The scope of this duty and the remedies for breach are heavily fact-specific. Sellers negotiating earnouts should insist on specific operating covenants, defined accounting methodologies, and clear dispute resolution procedures rather than relying on implied obligations.

A practical scenario illustrating closing risk: a strategic buyer acquires a software company using a stock purchase structure with a 12-month earnout tied to annual recurring revenue. Post-closing, the buyer redirects the target';s sales team to cross-sell the buyer';s existing products rather than the target';s standalone product. Revenue attributable to the earnout metric declines. The seller claims breach of the earnout covenant; the buyer argues it was exercising legitimate business judgment. Litigation follows, with costs on both sides running into the low millions of dollars and the outcome uncertain.

To receive a checklist on closing mechanics and post-closing risk management for US M&A transactions, send a request to info@vlolawfirm.com.

What is the biggest practical risk for a foreign buyer in a US M&A transaction?

The most significant practical risk is underestimating the regulatory complexity and timeline. Foreign buyers frequently focus on commercial negotiation and overlook the parallel tracks of HSR antitrust review, CFIUS national security review, and sector-specific regulatory approvals. Each track operates independently, and any one of them can delay or prevent closing. A buyer that has not planned for extended regulatory timelines may face pressure to close on unfavorable terms or risk losing the deal entirely. Engaging antitrust and CFIUS counsel before signing - not after - is the most effective way to manage this risk.

How long does a typical US M&A transaction take from signing to closing, and what does it cost?

Timeline varies significantly by transaction size and complexity. A straightforward private company acquisition with no antitrust issues and no CFIUS concerns can close in 30 to 60 days from signing. Transactions requiring HSR filing add at least 30 days for the initial waiting period, and a Second Request can extend the process by three to six months or more. CFIUS review adds a minimum of 30 days and potentially several months for complex cases. Legal fees for a mid-market transaction typically start from the low tens of thousands of dollars for simple deals and can reach seven figures for large, complex transactions with contested regulatory review. Buyers should also budget for RWI premiums, financial advisory fees, and the cost of post-closing integration.

When should a buyer choose a merger structure over an asset purchase or stock purchase?

A statutory merger is most appropriate when the buyer wants to acquire all assets and liabilities of the target by operation of law without the need to individually transfer each asset or obtain third-party consents for most contracts. It is also the standard structure for public company acquisitions, where the merger consideration is paid to all shareholders simultaneously and dissenting shareholders receive appraisal rights. An asset purchase is preferable when the buyer wants to select specific assets and exclude identified liabilities, even at the cost of greater transactional complexity and potential successor liability exposure. A stock purchase sits between the two: simpler than an asset purchase for contract continuity but carrying full historical liability exposure. The choice should be driven by the specific liability profile of the target, the tax objectives of both parties, and the practical requirements of the target';s key contracts and licenses.

US M&A transactions reward thorough preparation and penalize assumptions imported from other legal systems. The combination of state corporate law, federal antitrust and securities regulation, CFIUS oversight, and a highly developed contractual risk allocation framework creates a process that is sophisticated, time-consuming, and expensive to navigate without experienced counsel. Buyers and sellers who invest in early legal and regulatory analysis consistently achieve better outcomes than those who treat legal work as a closing formality.

Our law firm VLO Law Firms has experience supporting clients in the USA on M&A matters. We can assist with deal structure analysis, due diligence coordination, regulatory filing strategy, purchase agreement negotiation, and post-closing dispute resolution. To receive a consultation, contact: info@vlolawfirm.com.